Keystone Financial Group (Kentucky)’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Keystone Financial Group (Kentucky)'s GILD Position: Q2 2026 in Review
Keystone Financial Group (Kentucky) increased its Gilead Sciences (GILD) stake by 7.2% in Q2 2026, buying an estimated $36.8K and bringing the position to 4,142 shares worth $523K. The position accounts for 0.03% of the portfolio, ranked #320.
Keystone Financial Group (Kentucky) first reported a position in GILD in Q4 2017 and has held it in 21 quarters since. The position peaked at $538K in Q4 2025. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Keystone Financial Group (Kentucky) held 4,142 shares of Gilead Sciences worth $523K as of Q2 2026.
- Keystone Financial Group (Kentucky) bought 279 Gilead Sciences shares in Q2 2026, an estimated $36.8K.
- Gilead Sciences made up 0.03% of Keystone Financial Group (Kentucky)'s portfolio in Q2 2026, its #320 holding.
- Keystone Financial Group (Kentucky) first reported a position in Gilead Sciences in Q4 2017 and has held it in 21 quarters since.
- Keystone Financial Group (Kentucky)'s Gilead Sciences position peaked at $538K in Q4 2025.
- 2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Keystone Financial Group (Kentucky)'s 13F filing for Q2 2026, filed 29 Jul 2026.